Shanghai Micurx Pharmaceutical Co.,Ltd. Posted 244.5 Million Yuan Net Loss in First Three Quarters of 2023

Shanghai Micurx Pharmaceutical Co.,Ltd. (上海盟科药业股份有限公司) (688373.SH) reported a net loss of 244.5 million yuan in the first three quarters of 2023, widening 40.7% year-on-year.

Meanwhile, the company posted 68.3 million yuan in revenue, up 95.9% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 273.4 million yuan in total liabilities, with a liability-to-asset ratio of 21.4%.